ClinicalTrials.Veeva

Menu
Ameli BioGroup | London, United Kingdom logo

Ameli BioGroup | London, United Kingdom

Research site
About
We are a dedicated clinical trial site focused on connecting patients with innovative treatments and research opportunities. As a startup our mission is to bring cutting-edge clinical studies to our community, working closely with healthcare professionals, sponsors and patients. We prioritise safety, compassion and personalised care throughout the trial process, ensuring a supportive environment for all participants. By participating in our studies, patients contribute to meaningful medical advancements and gain access to potential new therapies and expert medical oversight.

Site insights

Top conditions

Top treatments

Rocatinlimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Ameli BioGroup

Verified by this site

Active trials

1 of 1 total trial

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

The main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PR...

Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Rocatinlimab

Trial sponsors

Amgen logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems